Central Phoenix Medical Clinic

Phoenix, Arizona 85020

0 studies enrolling now · 15 studies all time

What they study most

Cardiovascular Diseases, Coronavirus Disease, Diabetes Mellitus, Type 2, Dyslipidemia, Episodic Migraine, Lower Respiratory Tract Disease, Migraine, With or Without Aura, Obesity, Obstructive Sleep Apnea, Osteoarthritis, Knee, Overweight, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19

Studies at this site

• A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease — Completed
• A Study of Retatrutide (LY3437943) in Participants Who Have Obesity or Overweight — Completed
• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• A Study of an Ad26.RSV.preF-based Regimen in the Prevention of Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)-Confirmed Respiratory Syncytial Virus (RSV)-Mediated Lower Respiratory Tract Disease in Adults Aged 65 Years and Older — Stopped early
• A Study to Evaluate the Effect of ASP1941 in Adult Patients With Type 2 Diabetes Mellitus — Completed
• A Study of Ad26.COV2.S Administered as Booster Vaccination in Adults Who Have Previously Received Primary Vaccination With Ad26.COV2.S or BNT162b2 — Completed
• Glycemic Control and Treatment Satisfaction Using Finesse Versus Pen for Initiating Bolus Insulin Dosing in Type 2 Diabetes Patients — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants — Completed
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine — Completed
• A Study to Evaluate the Safety and Efficacy of JNJ-64565111 in Non-diabetic Severely Obese Participants — Completed
• An Extension Study to Evaluate the Long-Term Safety and Tolerability of Ubrogepant in the Treatment of Migraine — Completed
• The Efficacy and Safety of PRC-4016 in Hypertriglyceridemic Subjects — Completed
• Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus — Completed
• A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone — Completed